Gelonghui, January 2nd丨Jiangsu Hengrui Pharmaceuticals (600276.SH) announced that as of December 31, 2024, the company has repurchased a total of 5,181,144 shares through centralized bidding, accounting for 0.08% of the company's total share capital. The highest transaction price was 57.54 yuan/share, and the lowest was 39.00 yuan/share, with a total amount paid of 218,405,956.60 yuan (excluding transaction fees).
恒瑞医药(600276.SH)：累计回购518万股
Jiangsu Hengrui Pharmaceuticals (600276.SH): A total of 5.18 million shares have been repurchased.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney